Diflucan contains fluconazole, an oral antifungal that disrupts fungal cell-membrane production. It is used for susceptible Candida infections, including vaginal thrush caused by Candida albicans…
Diflucan contains fluconazole, an oral antifungal that disrupts fungal cell-membrane production. It is used for susceptible Candida infections, including vaginal thrush caused by Candida albicans. The regimen for the chosen strength should be confirmed with a healthcare professional before starting.
Diflucan contains fluconazole, an oral antifungal that disrupts fungal cell-membrane production. It is used for susceptible Candida infections, including vaginal thrush caused by Candida albicans. The regimen for the chosen strength should be confirmed with a healthcare professional before starting when vaginal candidiasis is clinically appropriate.
Diflucan contains fluconazole, a triazole antifungal medicine. The product form supplied here is a capsule containing fluconazole. Fluconazole acts against susceptible yeasts by inhibiting fungal enzymes required to produce ergosterol, a structural component of the fungal cell membrane.
The medicine is taken by mouth and reaches fungal cells through the bloodstream. Its activity is systemic, so it differs from creams or pessaries that act mainly at the site of application.
Fluconazole belongs to the triazole class of antifungals. It inhibits fungal cytochrome P450-dependent enzymes, especially lanosterol 14-alpha-demethylase. This reduces ergosterol production and weakens the fungal membrane, limiting fungal growth.
Diflucan is used for several susceptible fungal infections, including mucosal candidiasis, vaginal candidiasis, and selected systemic infections. The exact regimen depends on the infection, kidney function, age, pregnancy status, and other medicines being taken. The European Medicines Agency and HPRA product information describe fluconazole as a prescription antifungal requiring condition-specific dosing [1].
One practical detail is easy to miss: fluconazole stays in the body for a relatively long time. A person may continue to experience improvement after the capsule has been taken, even though no second dose is needed for many uncomplicated infections.
Diflucan is used against fungal infections caused by organisms susceptible to fluconazole. Candida albicans is the most frequent cause of vaginal thrush, although other Candida species can produce similar symptoms and may respond differently to treatment.
Vaginal candidiasis can cause itching, soreness, redness, discomfort during intercourse, and a thick or unusual discharge. Symptoms overlap with bacterial vaginosis, sexually transmitted infections, dermatitis, and urinary conditions. Fluconazole is appropriate only when the clinical diagnosis supports a susceptible fungal infection.
Fluconazole may also be prescribed for oral or oesophageal candidiasis and selected more serious infections. These uses require a different regimen from the 150 mg approach commonly used for uncomplicated vaginal candidiasis. The World Health Organization describes candidiasis as an infection caused by Candida yeasts, with treatment selected according to the site and severity of infection [2].
Symptoms that need clinical review include:
A single capsule is not suitable for every vaginal symptom. Persistent symptoms may mean the infection is caused by a non-albicans species, the diagnosis is different, or another treatment plan is needed.
For uncomplicated vaginal candidiasis, the regimen for the chosen strength should be confirmed with a healthcare professional before starting. The regimen should be assessed particularly carefully when symptoms are recurrent, pregnancy is possible, kidney disease is present, or other medicines are used.
The regimen for the chosen strength applies to a specific clinical situation. Oral fluconazole regimens for oral thrush, oesophageal candidiasis, cryptococcal disease, or recurrent vaginal candidiasis are different. Longer or repeated treatment should follow an individual prescription.
A common patient mistake is treating every recurrence with another single capsule. Recurrent vulvovaginal candidiasis can require confirmation of the organism, a longer induction course, and sometimes maintenance treatment. Repeated self-treatment can delay assessment of diabetes, resistant yeast, bacterial vaginosis, or a sexually transmitted infection.
Kidney impairment can change fluconazole dosing because the medicine is eliminated mainly through the kidneys. A prescriber may reduce the dose or adjust the interval when several doses are required. This adjustment is less relevant to a single dose but still belongs in the clinical assessment.
The medicine should not be used by a person with a previous serious allergic reaction to fluconazole or another azole antifungal.
Specific situations requiring medical review include:
Fluconazole inhibits several liver enzymes, including CYP2C9, CYP2C19, and CYP3A4. It can increase exposure to warfarin, some sulfonylureas, phenytoin, ciclosporin, tacrolimus, certain statins, and selected benzodiazepines. Warfarin users may need closer INR monitoring after fluconazole is started.
Do not combine fluconazole with quinidine, pimozide, or cisapride unless a specialist has explicitly directed the treatment. These combinations can raise the risk of serious cardiac rhythm disturbances. Rifampicin can reduce fluconazole exposure, while some other medicines can increase it.
A pharmacist or prescriber should also review supplements and non-prescription products. St John’s wort can alter the handling of many medicines, while products that affect heart rhythm or liver enzymes may add risk.
Not for you if you are pregnant and considering self-treatment, have had a serious azole allergy, or take medicines with important interactions; seek clinician advice instead.
Fluconazole capsules are commonly tolerated, though adverse effects can occur. Reported reactions include headache, nausea, abdominal discomfort, diarrhoea, vomiting, dizziness, and skin rash. The FDA prescribing information lists gastrointestinal symptoms, headache, and skin reactions among recognised adverse effects of fluconazole [3].
Most mild reactions settle without treatment. Taking the capsule with water and maintaining normal fluid intake may make nausea easier to manage. A mild headache can often be observed, but a severe or persistent headache needs clinical attention.
Contact urgent medical services for:
Rare liver injury has been reported with fluconazole. The risk deserves closer attention in people with liver disease or those taking other medicines that can affect the liver. Fluconazole can also prolong the QT interval in susceptible patients, which may increase the risk of an abnormal heart rhythm.
Clotrimazole cream and pessaries have a different tolerability profile because they are applied locally. Burning, itching, redness, or skin irritation can occur at the application site. Severe swelling or worsening irritation suggests intolerance rather than treatment success.
Fluconazole is a triazole antifungal that inhibits fungal cytochrome P450-dependent enzymes, particularly lanosterol 14-alpha-demethylase. By reducing ergosterol production, it weakens the fungal cell membrane and limits fungal growth.
Several practical errors can reduce the chance of a good result:
One detail patients often overlook is the difference between persistent infection and residual inflammation. Fungal growth may have stopped while irritated tissue still needs time to recover. A further capsule may add adverse-effect risk without improving the underlying irritation.
Another common mistake is sharing a capsule with a partner or household member. Similar symptoms can have different causes, and treatment should match the person and diagnosis.
Fluconazole and topical clotrimazole both treat susceptible vaginal thrush, but they use different routes. Fluconazole is taken orally and acts systemically. Clotrimazole cream and clotrimazole pessaries are applied locally, which can reduce exposure throughout the body.
| Treatment approach | Route and active ingredient | Main limitation |
|---|---|---|
| Diflucan 150 mg | Oral capsule containing fluconazole | Drug interactions and systemic adverse effects |
| Clotrimazole cream | Topical treatment containing clotrimazole | Local irritation; external cream may not treat internal infection alone |
| Clotrimazole pessary | Vaginal treatment containing clotrimazole | Local application can be inconvenient or irritating |
The oral route is convenient for people who prefer not to use a vaginal preparation. It can also be useful when external symptoms accompany internal infection, although symptom relief is not always immediate. The trade-off is greater potential for interactions with medicines processed through hepatic enzymes.
Topical clotrimazole may cause less systemic exposure. It can produce local burning, irritation, or discomfort, and the treatment course depends on the strength and formulation. Some vaginal products can weaken latex condoms or diaphragms during treatment, so the specific product instructions matter.
In clinical practice, the choice between oral and topical treatment is influenced by pregnancy, previous response, recurrence, medicine interactions, and patient preference. Oral fluconazole should not be used during pregnancy for routine vaginal thrush unless a prescriber has made a specific clinical decision. UK and European guidance generally favours a topical azole during pregnancy.
Doctors generally assess the diagnosis before selecting the dose. Vaginal itching alone does not prove Candida infection, and a capsule will not treat bacterial vaginosis, herpes, dermatitis, or most sexually transmitted infections.
A clinician also asks about pregnancy, recurrence, diabetes, immune suppression, recent antibiotics, and prior treatment response. These details change the preferred route or duration. For a first uncomplicated episode in a non-pregnant adult, a 150 mg oral dose may be appropriate when the diagnosis is clear. The decision also considers kidney function and possible medicine interactions. Follow-up is appropriate when symptoms persist or recur.
A useful clinical expectation is gradual symptom improvement rather than instant relief. Itching and soreness may take time to settle after fungal growth has been suppressed. Worsening symptoms, fever, pelvic pain, or no meaningful improvement require reassessment.
Fluconazole has a long elimination half-life of about 30 hours in adults with normal kidney function. That pharmacokinetic feature supports single-dose treatment for some infections, yet it does not make every fungal infection a single-dose condition. The EMA product information distinguishes regimens by infection site and severity [4].
The Diflucan capsule should be swallowed whole with water rather than split, crushed, or chewed. Capsules are not designed to provide a measured partial dose by opening them. The FDA fluconazole label in 2024 describes oral capsules as dosage forms intended for swallowing, with dosing selected according to the infection and patient factors. Taking the capsule whole also avoids inaccurate dosing and unpleasant taste.
Headache is a recognised adverse effect of fluconazole and may occur with or without nausea. Mild headache often settles, but severe headache with dizziness, fainting, visual symptoms, rash, or neurological changes needs prompt assessment. The HPRA product information published in 2024 lists headache among reported reactions to fluconazole. Do not take an extra capsule to treat a headache or to speed recovery.
A previous serious allergic reaction to fluconazole or another azole antifungal rules out further use unless a specialist provides a different plan. Pregnancy also changes treatment selection because routine oral fluconazole is generally avoided for uncomplicated vaginal thrush. NICE guidance reviewed in 2025 supports assessment of pregnancy and alternative topical treatment when appropriate. Liver disease, kidney impairment, and heart-rhythm disorders require additional review before dosing.
Fluconazole remains in the body for roughly 30 hours or longer, depending on kidney function. Its antifungal effect can continue after the capsule has been swallowed, while symptoms may take several days to improve. The WHO candidiasis guidance published in 2022 distinguishes pharmacological persistence from clinical recovery, which can vary with infection severity and tissue inflammation. A lack of immediate relief does not automatically justify another dose.
Fluconazole can interact with warfarin and may increase anticoagulant effect, so INR monitoring may be needed. It can also interact with phenytoin, ciclosporin, tacrolimus, some statins, and medicines that prolong the QT interval. The EMA safety information for fluconazole published in 2023 describes clinically relevant enzyme inhibition and interaction risks. Provide a complete list of prescription medicines, over-the-counter products, and supplements before treatment begins.
Older adults can receive fluconazole when the indication and kidney function support its use. Kidney function often declines with age, and dose or interval adjustments become more relevant during repeated treatment. The HPRA product information published in 2024 recommends renal assessment when multiple doses are prescribed. An older person taking warfarin, anti-seizure treatment, heart medicines, or several regular prescriptions needs an interaction review before use.
Your order will be securely packed and shipped within 24 hours. This is exactly what your package will look like (images of an actual item sent). It has the size and look of a regular private letter (24x11x0.7 cm) and its contents cannot be seen.
Based on 5 reviews
I used the 150 mg capsule after recurrent itching had been assessed as thrush. The irritation eased over the next couple of days, though I still had mild soreness at first. I did not take another dose when relief was not immediate.
7 Oct 2026The capsule was easier for me than using a pessary. I noticed a headache and mild nausea that evening, which settled by the following day. The treatment was convenient, but I would not use it again without checking my medicines first.
14 Oct 2026I had kidney problems and several regular prescriptions, so the clinician reviewed everything before choosing treatment. The infection improved, but the process was not as simple as taking a capsule without an assessment.
19 Oct 2026My symptoms returned after I treated myself once. Testing showed that the problem needed a different plan, so another single capsule would not have solved it. The useful part was finding the reason for the recurrence.
29 Oct 2026The dose was straightforward and I could take it with breakfast. I still had external irritation for a few days, so I used the locally recommended care as well. The medicine helped, but it did not provide instant comfort.
2 Nov 2026
